RETRACTED: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer’s Disease
A Retraction of the Original Research Article
Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
The journal retracts the 27 March 2020 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.
This retraction was approved by the Chief Editors of Frontiers in Cellular Neuroscience and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.
Citation: Frontiers Editorial Office (2021) Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease. Front. Cell. Neurosci. 15:728508. doi: 10.3389/fncel.2021.728508
Received: 21 June 2021; Accepted: 21 June 2021;
Published: 23 July 2021.
Approved by:
Dirk M. Hermann, University of Duisburg-Essen, GermanyCopyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZSYjeDAwMDQwO2Zyb250aWVyc2luLm9yZw==